Botox is an injection that briefly reduces the force of expression muscles so that lines that deepen with movement form less. Filler places material in a hollowed or flattened site and changes volume and contour. The needle may look the same, but the roles differ.
3-line summary
1. Botox briefly reduces muscle signals, and filler fills a hollowed site.
2. With Botox, force begins to drop after a day or two, and with filler, volume is visible immediately on placement. Duration is split by material and site.
3. If filler enters a blood vessel, there are reports of skin necrosis, vision injury, and stroke, and Botox carries warnings of eyelid drooping and swallowing or breathing difficulty.
Expression wrinkles and hollowed sites are separated
Botulinum toxin, called Botox, is a medicine that briefly reduces the signal telling a nerve to give a muscle force. U.S. approval documents describe this medicine as an injection that blocks nerve·muscle signals, and in aesthetics it is used on lines made by movement, such as the glabella, the eye area, and the forehead.
Filler places material to fill a groove or, as with the cheeks, lips, chin, or the back of the hands, raises the height of a hollowed site. As U.S. regulatory guidance states, how long the effect lasts is split by material and the site of placement. Material types can be read further in the filler types guide.
| Item | Botox | Filler |
|---|---|---|
| What it does | Briefly reduces the force of expression muscles | Fills volume into a hollowed site |
| Matching sites | Lines made by movement, such as the forehead, glabella, and eye area | Hollowed sites such as the cheeks, lips, and nasolabial grooves |
| When it starts to show | After a day or two; force drops further in the first week | Volume is visible immediately on placement. Swelling lasts several days |
| Duration | For the glabella, around three to four months | Split by material and site |
| Common reactions | Pain, bruising, headache, drooping of the eyelid or brow | Swelling, bruising, pain, redness |
※ Botox timing and duration follow a specific product’s aesthetic approval document; filler duration follows regulatory-agency guidance. Forehead lines can be separated by site in the forehead wrinkle guide, and eye-area lines in the eye-area wrinkle guide.
What happens on the injection day
Both are finished by injection. Botox identifies muscle sites and places small amounts divided across several points, and filler pushes material over bone or under the skin. Same-day daily activity is split by swelling and bruising, and the next steps, such as makeup and exercise, are decided while watching the reaction at the injection sites.
Botox products do not share interchangeable units. Numbers from a product used in the past are not transferred as-is to a different product. Fillers have approved face and hand sites set per product, so today’s name and site are confirmed, then the injection is given.
When planning both on one face
Forehead lines have movement reduced with Botox, and cheek hollowing is filled with filler, in a way that divides the sites. At sites such as the mouth area, where movement and volume overlap, the order is set by looking at the goal. Whether they are done the same day or spaced apart is chosen after looking at swelling at that site and the vessel paths.
If previously used products, sites, and dates remain on record, they become the starting point for rewriting the plan. Schedules that overlap with energy-based procedures can be checked in the prior injection history guide.
Common reactions and serious events
Botox approval documents warn that the effect can spread from the injection site, with reports of swallowing, speech, and breathing becoming difficult. Symptoms may appear hours to weeks later, and there are reports that swallowing and breathing difficulty have threatened life. After glabellar injection, eyelid drooping; at the eye area, eyelid swelling; and at the forehead, headache and brow drooping are listed as common reactions in the approval documents.
For filler, the event regulatory agencies record as serious is material entering a blood vessel. If a vessel is blocked, there are reports leading to skin necrosis, vision injury, and stroke. Published vision-injury cases clustered at the nose, forehead, and glabella, and hyaluronic acid material accounted for a substantial portion of the cases. Reports in which vision did not return were a majority. Hyaluronic acid is described as easier to remove than permanent materials, but vascular events occur with that material as well.
Common swelling, bruising, and pain often settle over several days to several weeks. With filler, inflammation or a palpable lump may also appear weeks, months, or years later.
| Signal to seek medical care immediately | Botox | Filler |
|---|---|---|
| Swallowing, speech, or breathing becomes difficult | Approval-document warning | — |
| Severe pain, a change in vision, skin turning white or blue | — | Sign of a vascular event |
| Speech or limb strength drops, or walking becomes difficult | Sign of effect spread | Also described as a stroke sign |
Human data in pregnancy are blank, and animal studies showed effects on fetal growth. Data on transfer into breast milk during lactation are also blank. Infection at the injection site, hypersensitivity to toxin components, conditions in which muscle strength is easily lost, and certain antibiotics or muscle relaxants lead to rescheduling.
Cost is split by dose and product count
For Botox, units and point count split the cost; for filler, syringe count and material split it. As sites increase, dose increases, and even on the same face, dividing movement sites from hollowed sites records two line items. Specific amounts are not written in this article.
Questions to confirm before treatment
Asking the five below before treatment settles whether today’s injection is for movement or for volume.
- □ Whether today’s product is a medicine that reduces muscle force, or a material that fills volume
- □ The product name, and the approved sites for that product
- □ Whether Botox units were converted against another product’s numbers
- □ Whether filler is being placed in the nose, forehead, or glabella, and a contact to notify immediately if vision or skin color changes
- □ Pregnancy or breastfeeding, injection-site infection, neuromuscular disease, and recently used antibiotics or muscle relaxants
Frequently asked questions
Q1. Does it hurt?
Both have injection pain. With filler, pressure of pushing the material is added. Pain is concentrated right after the injection, and same-day bruising and swelling follow.
Q2. How many sessions?
For Botox, the next appointment is set again to match the cycle when movement returns. For filler, the next time point is set by looking at how fast the material decreases and at the site.
Q3. How long does it last?
With Botox, force returns when nerve signals reconnect. With filler, volume lowers as the material decreases, and the period is split by material and the site of placement.
Q4. Can they be done together?
Movement sites and hollowed sites can be planned together on one face. A day of overlapping them at the same point is chosen after looking at swelling.
Q5. Who postpones the appointment?
Pregnancy or breastfeeding and injection-site infection postpone both. For toxin, conditions in which muscle strength is easily lost and certain medicines are also reviewed; for filler, material allergy is reviewed in addition.
Results, duration, and suitability vary with individual skin condition, age, and lifestyle, and the same outcome cannot be guaranteed.
Procedures may cause temporary redness or swelling, and contraindications may apply, so please confirm these during your consultation.
This article is general information and does not replace individual medical care. Please confirm diagnosis and treatment suited to your condition during a consultation.
Sources
- U.S. FDA: BOTOX Cosmetic (onabotulinumtoxinA) prescribing information
- U.S. FDA: Dermal Fillers (Soft Tissue Fillers)
- Doyon VC et al. (2024), Aesthet Surg J: Update on Blindness From Filler: Review of Prognostic Factors, Management Approaches, and a Century of Published Cases (PMID 38630871)
- Sito G et al. (2019), J Clin Aesthet Dermatol: Vascular Complications after Facial Filler Injection: A Literature Review and Meta-analysis (PMID 31360292)
Related reading
Discuss options for your current needs
We review your current health and prior procedures before explaining appropriate options and their limits.
